UNCY Award Disclosure
Manning Meredith · SEC Form 4 · Filed Oct 29, 2026
Award
Calculated transaction value
$0
Manning Meredith Director
UNCY
Transaction date
Oct 28, 2026
Public filing date
Oct 29, 2026
Filing lag
Filed 1 day later
UNCY daily price context
Close on/before transaction
$3.76
Oct 28, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options on Common Stock
- Quantity / price
- 27,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-113840
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Unicycive Therapeutics, Inc. UNCY | Award | Oct 28, 2026 | $0 |
| Unicycive Therapeutics, Inc. UNCY Current | Award | Oct 28, 2026 | $0 |